Acadia Pharmaceuticals Inc Liquidation Value
ACAD
Other
Cash & Equivalents
$177.69M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $177.69M
Total Obligations: -$329.30M
$-151.61M
Per share: $-0.89
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $177.69M
AR: $121.46M
Total Obligations: -$329.30M
$-30.15M
Per share: $-0.18
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $177.69M
AR: $121.46M
Inventory: $111.37M
Total Obligations: -$329.30M
$81.22M
Per share: $0.48
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-151.61M | $-0.89 |
| Liquid Liquidation Value | $-30.15M | $-0.18 |
| Operating Liquidation Value | $81.22M | $0.48 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $177.69M |
| Accounts Receivable | $121.46M |
| Inventory | $111.37M |
| Current Liabilities | $277.11M |
| Long-term Debt | N/A |
| Op. Lease Liability | $52.19M |
| Finance Lease | N/A |
| Shares Outstanding | 170.3M |
Explore all 190 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $177.69M | $121.46M | $111.37M | $10.90M | $277.11M | N/A | $52.19M | N/A |
| 2025-09-30 | $258.00M | $115.85M | $105.98M | $21.75M | $356.58M | N/A | $54.81M | N/A |
| 2025-06-30 | $253.64M | $107.50M | $110.53M | $20.10M | $330.02M | N/A | $56.29M | N/A |
| 2025-03-31 | $217.70M | $105.74M | $102.97M | $18.09M | $302.53M | N/A | $56.01M | N/A |
▼ Community Notes